Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview.

Suppr

超能文献

作者信息

Bjarnason I, Peters T J

机构信息

Sect Gastroenterology MRC Clinical Research Centre, Harrow, Middlesex, United Kingdom.

出版信息

Gut. 1989 Nov;30 Spec No(Spec No):22-8. doi: 10.1136/gut.30.spec_no.22.

DOI:10.1136/gut.30.spec_no.22

PMID:2691345

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1440693/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f1/1440693/b6d5012497f1/gut00226-0031-a.jpg

相似文献

Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview.

Gut. 1989 Nov;30 Spec No(Spec No):22-8. doi: 10.1136/gut.30.spec_no.22.

Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

Gut. 1992 Sep;33(9):1204-8. doi: 10.1136/gut.33.9.1204.

Intestinal permeability and inflammation in patients on NSAIDs.

Gut. 1998 Oct;43(4):506-11. doi: 10.1136/gut.43.4.506.

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.

J Gastroenterol. 2009;44 Suppl 19:23-9. doi: 10.1007/s00535-008-2266-6. Epub 2009 Jan 16.

Helping the mucosa make sense of macromolecules.

Gut. 1987 Sep;28(9):1057-61. doi: 10.1136/gut.28.9.1057.

Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings.

Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:10-5; discussion 15-6. doi: 10.1111/j.1365-2036.1997.tb00804.x.

[Adverse effects of non-steroidal anti-inflammatory drugs in the lower gastrointestinal tract].

Orv Hetil. 2009 Jan 4;150(1):27-34. doi: 10.1556/OH.2009.28508.

[Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].

Z Rheumatol. 1988 May-Jun;47(3):156-60.

Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function.

Scand J Gastroenterol Suppl. 1997;223:70-8.

Nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease.

Am J Gastroenterol. 2000 Aug;95(8):1859-61. doi: 10.1111/j.1572-0241.2000.02241.x.

引用本文的文献

Distribution of endotoxin in maternal and fetal body with intrahepatic cholestasis of pregnancy and its association with adverse fetal outcome.

BMC Pregnancy Childbirth. 2022 Dec 8;22(1):920. doi: 10.1186/s12884-022-05235-4.

Long-Term Outcomes of NSAID-Induced Small Intestinal Injury Assessed by Capsule Endoscopy in Korea: A Nationwide Multicenter Retrospective Study.

Gut Liver. 2015 Nov 23;9(6):727-33. doi: 10.5009/gnl14134.

Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

World J Gastroenterol. 2013 Mar 28;19(12):1861-76. doi: 10.3748/wjg.v19.i12.1861.

Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

World J Gastroenterol. 2011 Mar 21;17(11):1416-26. doi: 10.3748/wjg.v17.i11.1416.

Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.

Dig Dis Sci. 2004 Oct;49(10):1569-74. doi: 10.1023/b:ddas.0000043365.39251.6e.

Intestinal permeability, leaky gut, and intestinal disorders.

Curr Gastroenterol Rep. 1999 Oct;1(5):410-6. doi: 10.1007/s11894-999-0023-5.

Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability.

Dig Dis Sci. 1993 Mar;38(3):417-25. doi: 10.1007/BF01316493.

Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.

Gut. 1993 Nov;34(11):1535-8. doi: 10.1136/gut.34.11.1535.

Duodenal diaphragmlike stricture induced by acetylsalicylic acid.

Dig Dis Sci. 1994 Jun;39(6):1365-9. doi: 10.1007/BF02093806.

Short term effects of indomethacin on rat small intestinal permeability. Role of eicosanoids and platelet activating factor.

Gut. 1994 Apr;35(4):490-5. doi: 10.1136/gut.35.4.490.

本文引用的文献

Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.

Br J Rheumatol. 1983 Nov;22(4 Suppl 2):75-82. doi: 10.1093/rheumatology/xxii.suppl_2.75.

The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.

Br J Rheumatol. 1983 Nov;22(4 Suppl 2):53-66. doi: 10.1093/rheumatology/xxii.suppl_2.53.

Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.

Gastroenterology. 1983 Aug;85(2):318-22.

Possible role of enteric organisms in the pathogenesis of ankylosing spondylitis and other seronegative arthropathies.

Infect Immun. 1983 Sep;41(3):935-41. doi: 10.1128/iai.41.3.935-941.1983.

Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.

Lancet. 1984 Nov 24;2(8413):1171-4. doi: 10.1016/s0140-6736(84)92739-9.

A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test.

Lancet. 1983 Feb 12;1(8320):323-5. doi: 10.1016/s0140-6736(83)91628-8.

Arthritis associated with Salmonella infections.

Ann Rheum Dis. 1970 Sep;29(5):483-7. doi: 10.1136/ard.29.5.483.

Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders.

Gastroenterology. 1974 Sep;67(3):531-50.

Rheumatoid arthritis and the gut.

Br J Rheumatol. 1986 May;25(2):138-40. doi: 10.1093/rheumatology/25.2.138.

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

Gastroenterology. 1987 Sep;93(3):480-9. doi: 10.1016/0016-5085(87)90909-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验